PD-Rx Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PDRX research report →
Companywww.pdrx.com
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company provides approximately 2,600 prepackaged medications; and creams, ointments, ophthalmics, otics, liquids, suspensions, etc.
- CEO
- Robert D. Holsey
- IPO
- 2003
- Employees
- 28
- HQ
- Oklahoma City, OK, US
Price Chart
Valuation
- Market Cap
- $5.75M
- P/E
- -20.10
- P/S
- 0.31
- P/B
- 0.51
- EV/EBITDA
- 0.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- -2.60%
- Net Margin
- -1.40%
- ROE
- -2.48%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $18.35M · -3.15%
- Net Income
- $-257,523 · 65.82%
- EPS
- $-0.17 · 63.04%
- Op Income
- $-477,417
- FCF YoY
- 153.37%
Performance & Tape
- 52W High
- $3.35
- 52W Low
- $2.41
- 50D MA
- $3.34
- 200D MA
- $3.06
- Beta
- -1366978.48
- Avg Volume
- 75
Get TickerSpark's AI analysis on PDRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PDRX Coverage
We haven't published any research on PDRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PDRX Report →